[Federal Register Volume 73, Number 78 (Tuesday, April 22, 2008)]
[Notices]
[Page 21630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-8643]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Addressing Barriers to Diagnosis and Genetic 
Testing for Duchenne Muscular Dystrophy, Potential Extramural Projects 
(PEP) 2008-R-12

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 1 p.m.-2 p.m., May 16, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Addressing Barriers to Diagnosis and 
Genetic Testing for Duchenne Muscular Dystrophy, PEP 2008-R-12.''
    Contact Person for More Information: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-8643 Filed 4-21-08; 8:45 am]
BILLING CODE 4163-18-P